Valsartan
  
Side effects 
	
		
Options: 
			
			Hide MedDRA Preferred Terms
			
		
	
	
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 
| Headache | Headache | 8.5% | 13.6% | x | x | x | x | x | x | x | x | x | x | x | 
| Diarrhoea | Diarrhoea | 2.5% - 5% | 1.6% - 4% | x | x | x | x | x | x | x | x | x | x | x | 
| Infection | Infection | 3.3% | 2.6% |  |  |  |  |  |  |  |  |  |  | x | 
| Infestation | Infestation NOS | 3.3% | 2.6% |  |  |  |  |  |  |  |  |  |  | x | 
| Viral infection | Viral infection | 3.1% - 3.3% | 2.6% | x | x | x | x | x | x | x | x | x | x | x | 
| Arthralgia | Arthralgia | 1.3% - 3% | 0.9% - 2% | x | x | x | x | x | x | x | x | x | x | x | 
| Musculoskeletal discomfort | Arthralgia | 1.3% - 3% | 0.9% - 2% | x | x | x | x | x | x | x | x | x | x | x | 
| Myalgia |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Back pain | Back pain | 2.2% - 3% | 1.5% - 2% | x | x | x | x | x | x | x | x | x | x | x | 
| Asthenia | Fatigue | uncommon, 1.9% - 3% | 1.3% - 2% | x | x | x | x | x | x | x | x | x | x | x | 
| Asthenia | uncommon |  | x | x | x | x | x | x | x | x | x | x | x | 
| Fatigue | Fatigue | uncommon, 1.9% - 3% | 1.3% - 2% | x | x | x | x | x | x | x | x | x | x | x | 
| Upper respiratory tract infection | Upper respiratory tract infection | 2.9% | 2.3% | x | x | x | x | x | x | x | x | x | x | x | 
| Dizziness | Dizziness | common, 2% - 17% | 1% - 9% | x | x | x | x | x | x | x | x | x | x | x | 
| Syncope |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Cough | Cough | uncommon, 0.6% - 2.7% | 1.3% | x | x | x | x | x | x | x | x | x | x | x | 
| Dry cough |  |  |  | x | x | x | x | x | x | x | x | x |  | 
| Hyperkalaemia | Hyperkalaemia | postmarketing — 2% | 1% | x | x | x | x | x | x | x | x | x | x | x | 
| Hypotension | Hypotension | common, 0.8% - 7% | 1% - 2% |  | x |  | x | x | x | x | x | x | x | x | 
| Rhinitis | Rhinitis | 1.8% | 2% | x | x | x | x | x | x | x | x | x | x | x | 
| Nausea | Nausea | uncommon, 1.5% | 2.2% | x | x | x | x | x | x | x | x | x | x | x | 
| Sinusitis | Sinusitis | 1.5% | 1.7% | x | x | x | x | x | x | x | x | x | x | x | 
| Abdominal pain | Abdominal pain | 1.3% | 0.9% | x | x | x | x | x | x | x | x | x | x | x | 
| Gastrointestinal pain | Abdominal pain | 1.3% | 0.9% | x | x | x | x | x | x | x | x | x | x | x | 
| Pharyngitis | Pharyngitis | 1.3% | 0.7% | x | x | x | x | x | x | x | x | x | x | x | 
| Bronchitis | Bronchitis | 1.1% | 1.3% | x |  |  |  |  |  |  |  |  |  |  | 
| Dyspepsia | Dyspepsia | 1.1% | 1.8% | x | x | x | x | x | x | x | x | x | x | x | 
| Oedema | Oedema | uncommon |  |  | x | x | x | x | x | x | x | x | x | x | 
| Cardiac failure | Cardiac failure | uncommon |  |  |  |  |  |  |  |  |  |  |  | x | 
| Vertigo | Vertigo | uncommon |  | x | x | x | x | x | x | x | x | x | x | x | 
| Insomnia | Insomnia | uncommon |  |  | x | x | x | x | x | x | x | x | x | x | 
| Loss of libido | Loss of libido | uncommon |  |  |  |  |  |  |  |  |  |  |  | x | 
| Blood creatinine increased | Blood creatinine increased | 0.4% - 0.6% |  | x |  | x | x | x | x | x | x |  | x |  | 
| Serum creatinine increased |  |  | x |  |  |  |  |  |  |  |  |  | x | 
| Dermatitis | Rash | very rare, 0.2% - 0.6% |  | x | x | x | x | x | x | x | x | x | x | x | 
| Rash | Rash | very rare, 0.2% - 0.6% |  | x | x | x | x | x | x | x | x | x | x | x | 
| Alopecia | Alopecia | postmarketing |  |  | x | x | x | x | x | x | x | x | x |  | 
| Angioedema | Angioedema | very rare, postmarketing |  | x | x | x | x | x | x | x | x | x | x | x | 
| Hepatitis | Hepatitis | postmarketing |  |  | x | x | x | x | x | x | x | x | x | x | 
| Hypersensitivity | Hypersensitivity | very rare, postmarketing |  | x | x | x | x | x | x | x | x | x | x | x | 
| Renal failure | Renal failure | postmarketing |  | x |  |  |  |  |  | x | x | x | x |  | 
| Renal impairment | very rare — common |  | x | x | x | x | x | x | x | x | x | x | x | 
| Rhabdomyolysis | Rhabdomyolysis | postmarketing |  | x |  | x | x | x | x | x | x | x | x | x | 
| Thrombocytopenia | Thrombocytopenia | postmarketing |  | x |  | x | x | x | x | x | x | x | x | x | 
| Vasculitis | Vasculitis | postmarketing |  |  |  |  | x | x | x | x | x | x | x | x | 
| Dermatitis bullous | Dermatitis bullous | postmarketing |  |  |  |  |  |  |  |  |  | x | x | x | 
| Hepatic enzyme increased | Hepatic enzyme increased | postmarketing |  |  | x | x | x | x | x | x | x | x | x | x | 
| Renal impairment | Renal impairment | very rare — common |  | x | x | x | x | x | x | x | x | x | x | x | 
| Renal failure acute | Renal failure acute | very rare |  | x |  |  |  |  |  |  |  |  |  | x | 
| Pruritus | Pruritus | very rare |  | x | x | x | x | x | x | x | x | x | x | x | 
| Serum sickness | Serum sickness | very rare |  |  |  |  |  |  |  |  |  |  |  | x | 
| Anaphylactic shock | Anaphylactic shock |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Decreased appetite | Anorexia |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Anxiety | Anxiety |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Atrial fibrillation | Atrial fibrillation |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Mental disorder | Mental disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Chest pain | Chest pain |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Connective tissue disorder | Connective tissue disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Constipation | Constipation |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Dysgeusia | Dysgeusia |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Dyspnoea | Dyspnoea |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Epistaxis | Epistaxis |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Flatulence | Flatulence |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Gastrointestinal disorder | Gastrointestinal disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Cardiac disorder | Cardiac disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Haemorrhage | Haemorrhage |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Haemoglobin | Haemorrhage |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Hyponatraemia | Hyponatraemia |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Orthostatic hypotension | Orthostatic hypotension |  |  | x |  |  |  |  |  |  |  |  |  | x | 
| Immune system disorder | Immune system disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Renal failure chronic | Renal failure chronic |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Mediastinal disorder | Mediastinal disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Muscle spasms | Cramp muscle |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Myositis | Myositis |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Nervous system disorder | Nervous system disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Neutropenia | Neutropenia |  |  | x | x | x |  |  |  |  |  |  |  | x | 
| Palpitations | Palpitations |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Paraesthesia | Paraesthesia |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Swelling | Swelling |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Shock | Syncope |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Syncope | Syncope |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Loss of consciousness | Syncope |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Urethral disorder | Urinary tract disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Urinary tract disorder | Urinary tract disorder |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Urticaria | Urticaria |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Angiopathy | Angiopathy |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Vomiting | Vomiting |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Dry mouth | Dry mouth |  |  |  | x | x | x | x | x | x | x | x | x | x | 
| Microcytic anaemia | Microcytic anaemia |  |  | x | x | x |  |  |  |  |  |  |  | x | 
| Acute interstitial pneumonitis | Hamman-Rich syndrome |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Idiopathic pulmonary fibrosis | Hamman-Rich syndrome |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Blood urea increased | Blood urea increased |  |  | x |  |  |  |  |  |  |  |  |  | x | 
| Muscular weakness | Muscular weakness |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Hypogeusia | Hypogeusia |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Malnutrition | Malnutrition |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Skin disorder | Unspecified disorder of skin and subcutaneous tissue |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Myalgia | Myalgia |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Abdominal pain upper | Abdominal pain upper |  |  |  | x | x | x | x | x | x | x | x | x |  | 
| Dizziness postural | Dizziness postural |  |  |  |  |  |  |  |  |  |  |  |  | x | 
| Erectile dysfunction | Erectile dysfunction |  |  | x | x | x | x | x | x | x | x | x | x | x | 
| Vision blurred | Vision blurred |  |  |  | x | x | x | x | x | x | x | x | x |  | 
| Photosensitivity reaction | Photosensitivity |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Blood pressure increased | Blood pressure increased |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Blood potassium increased | Serum potassium increased |  |  | x | x | x |  |  |  |  |  |  |  | x | 
| Drug interaction | Drug interaction |  |  |  | x | x | x | x | x | x | x | x | x |  | 
| Ageusia | Ageusia |  |  | x |  |  |  |  |  |  |  |  |  |  | 
| Somnolence | Somnolence |  |  | x | x | x | x | x | x | x | x | x | x | x | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 56 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 51 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 53 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 52 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 52 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 52 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 53 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 53 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 53 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 54 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 75 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |